Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis. - Wikidata - awgldk - TriplyDB

Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.

Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.

http://www.wikidata.org/entity/Q36640360

about

Apoptotic cell clearance: basic biology and therapeutic potential.Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy Association of plasma levels of Protein S with disease severity in multiple sclerosis.MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.Diversification of TAM receptor tyrosine kinase function Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages.MERTK as negative regulator of human T cell activation TAM receptor signaling in immune homeostasis.The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease.Biology of the TAM receptors.Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4+CD25+ Regulatory T Cells Mainly through Axl Receptor SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis.Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology.Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.Recombinant Gas6 augments Axl and facilitates immune restoration in an intracerebral hemorrhage mouse model.Protective Effects of Pterostilbene Against Myocardial Ischemia/Reperfusion Injury in Rats.Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models.Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis

P2860

Q26825935-F11B6BDB-DED1-4B46-BF92-7F02313C629D Q27334880-F6100F8E-9817-43AA-8576-27A1261E7D63 Q27928010-2BF45295-5057-4AAF-A524-871E6EC0A0E9 Q33692556-7422B8EE-5571-471F-9F02-4841F3A0097C Q33849824-92B31883-66A4-4D2F-A301-C968A8BC74C5 Q34077622-31AE99D2-40F5-46E8-B6F1-79775D43017B Q34214465-3939B4AC-4021-4398-9360-DA900C1B8E4C Q34390266-40239CCE-96DF-4988-A20B-744763488B0B Q34597949-C0D28E71-2705-494C-BE21-839906D5BAC2 Q35070525-4C1A414C-59C6-4BBD-A649-69CDCB2FCAFF Q35207099-AE4DDAE3-1569-4AE4-9CF9-300281BFF54D Q35819380-DCA35911-8F02-43E6-ACE9-A3ABC90708B0 Q36359800-72DFA2E0-BD22-44E9-8F57-54A107423D1D Q36933960-3C3187F1-E1FB-4BC3-84A5-83F081024692 Q37258717-A3B482FB-1C05-42C2-86DF-6EC9B9D555DD Q37657343-E5BF4329-2AA7-4F51-A84A-1252C37910D8 Q38193362-1B50AC57-4FDF-458B-9350-D846E066BF9A Q39215790-D8615BC0-0896-4071-8B96-5945C010B2EC Q41677325-1940A586-E26A-42DA-BDFE-3747075018DD Q42712047-9B1C51FA-ACFA-4D38-805C-7F31C4716F66 Q47189951-E707B641-67CD-4BC3-A732-4041F8339627 Q48634442-2DCEC586-5C2D-41AD-A69C-8C8A2470AAAC Q48880463-1C3D5F15-2775-456C-BC60-3388FD6382B4 Q54225679-E3F14F36-8A24-40CB-A37C-34DCA2E355FC Q58601804-51DE7CD0-8F36-40AF-8DF2-AC1FBFE22818

P2860

Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.

http://www.wikidata.org/entity/Q36640360

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@ast

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@en

type

label

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@ast

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@en

prefLabel

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@ast

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@en

P1433

Q36640360-D2724A9B-B3B2-4A59-BC7B-0C86C7C6EE1B

P1476

Q36640360-E0E5C863-BBB8-468F-903B-1FDCD15F5EBC

P2093

Q36640360-53AD4ED8-F4A9-4660-A32E-5A560D3500CA

Q36640360-5BA5E619-06CB-4600-9BCE-A8A526C559D0

Q36640360-5C39FBBB-B7B8-4DCC-93F1-49A5FAC7D794

Q36640360-62E5B521-E79A-4A58-80E9-A4D0768D26AE

Q36640360-6BC1C0F9-4764-4CD8-83DA-B80277FCA13B

Q36640360-97A60C3C-5757-4098-AA1A-ACC3524A286D

Q36640360-BE2AABB1-1090-4387-BD06-BF58626772D3

Q36640360-EB20E055-75C4-4AD6-8399-351558C2CDD9

P2860

Q36640360-02EC9789-B09D-49C4-9421-8A4A2759862E

Q36640360-232A6166-2F91-4279-857F-2B51EA03A3E9

Q36640360-2F4FAF5B-F215-4874-B95E-F9E4A7D51053

Q36640360-3C65D86A-400C-44F1-87E8-8A8F331DC43D

Q36640360-4463888C-6E4A-421E-995A-3A45643040CD

Q36640360-56A73F4C-260D-47F6-A020-D41974224DC0

Q36640360-5FB7D653-BAA1-4224-9B31-1B9EC4E2EA33

Q36640360-63C0066D-2703-4F4C-AA84-6749DA255649

Q36640360-69B0F60A-8D33-4ADF-9F97-1093A757ECF0

Q36640360-7A4C8BA8-AF4A-405E-82DD-5AFCF614BB69

P304

Q36640360-BEB522D5-46BE-41AB-8F13-0C5522BE1C37

P31

Q36640360-1E4A4B82-0471-4018-80CD-AF658CFA6CBC

P356

Q36640360-FCADD7D3-6EF1-4D45-8ED5-A4ADBAF73F70

P433

Q36640360-AFE6C259-E2B3-4101-A06E-BEDE3B282E13

P478

Q36640360-C2ECEAF3-8627-4928-A9D3-6878C4EDB588

P577

Q36640360-DC374106-A8D1-422D-AFE7-0D0EA840EFBB

P698

Q36640360-0F2018EA-228F-4B7D-B33B-96F834E9241E

P932

Q36640360-9B7CB3A6-7A57-4188-B325-DE654D8E5C50

P356

P1433

Arthritis & Rheumatology

P1476

Therapeutic efficacy of Tyro3, ...... in collagen-induced arthritis.

@en

P2093

B T van den Brand

http://www.w3.org/2001/XMLSchema#string

C V Rothlin

http://www.w3.org/2001/XMLSchema#string

E A Vermeij

http://www.w3.org/2001/XMLSchema#string

F A J van de Loo

http://www.w3.org/2001/XMLSchema#string

M B Bennink

http://www.w3.org/2001/XMLSchema#string

O J Arntz

http://www.w3.org/2001/XMLSchema#string

S Abdollahi-Roodsaz

http://www.w3.org/2001/XMLSchema#string

W B van den Berg

http://www.w3.org/2001/XMLSchema#string

P2860

TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages

Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family

TAM receptors are pleiotropic inhibitors of the innate immune response

Phagocytosis and clearance of apoptotic cells is mediated by MER.

The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.

Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance.

Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice.

Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

MerTK is required for apoptotic cell-induced T cell tolerance.

SOCS proteins, cytokine signalling and immune regulation.

P304

671-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.37786

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23203851

http://www.w3.org/2001/XMLSchema#string

P932

3582862

http://www.w3.org/2001/XMLSchema#string